Merck & Co.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Merck & Co. generated cash of $13,006,000,000, which is less than the previous year. Cash used in financing activities reached the amount of -$4,810,000,000 last year. Net change in cash is therefore -$5,864,000,000.
Cash Flow
| 2014 | 7.86B | -374M | -15.11B |
|---|---|---|---|
| 2015 | 12.42B | -4.75B | -5.38B |
| 2016 | 10.37B | -3.21B | -9.04B |
| 2017 | 6.44B | 2.67B | -10.00B |
| 2018 | 10.92B | 4.31B | -13.16B |
| 2019 | 13.44B | -2.62B | -8.86B |
| 2020 | 10.25B | -9.44B | -2.83B |
| 2021 | 14.10B | -16.55B | 2.59B |
| 2022 | 19.09B | -4.96B | -9.11B |
| 2023 | 13.00B | -14.08B | -4.81B |
0QAH.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 12.77B | 8.16B | 8.15B | 9.93B | 7.96B | 6.09B | 6.51B | 8.52B | 7.44B | 15.62B |
Operating activities | ||||||||||
Net income | 365M | 14.52B | 12.35B | 7.08B | 9.77B | 6.19B | 2.41B | 3.94B | 4.45B | 11.93B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 3.87B | 3.90B | 3.21B | 3.62B | 3.65B | 4.51B | 4.63B | 5.44B | 6.37B | 6.69B |
Stock-based compensation expense | 645M | 541M | 479M | 441M | 417M | 348M | 312M | 300M | 299M | 278M |
| Deferred income tax benefit | 645M | 541M | 479M | 441M | 417M | 348M | 312M | 300M | 299M | 278M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -1.14B | -644M | -2.03B | -1.00B | 294M | -418M | 297M | -619M | -480M | -554M |
Inventories | -816M | -161M | -674M | -855M | -508M | -911M | -145M | 206M | 805M | 79M |
Accounts payable | -380M | -289M | 405M | 724M | 399M | 230M | 254M | 278M | -37M | 593M |
Cash generated by operating activities | 13.00B | 19.09B | 14.10B | 10.25B | 13.44B | 10.92B | 6.44B | 10.37B | 12.42B | 7.86B |
Investing activities | ||||||||||
Purchases Of Investments | -955M | -1.20B | -1M | -1.09B | -3.20B | -7.99B | -10.73B | -15.65B | -16.68B | -24.94B |
Investments In Property Plant And Equipment | -3.86B | -4.38B | -4.44B | -4.68B | -3.47B | -2.61B | -1.88B | -1.61B | -1.28B | -2.31B |
Acquisitions Net | -12.03B | -121M | -12.90B | -6.60B | -4.95B | -431M | -396M | -780M | -7.42B | 11.23B |
Cash generated by investing activities | -14.08B | -4.96B | -16.55B | -9.44B | -2.62B | 4.31B | 2.67B | -3.21B | -4.75B | -374M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 384M | 3.64B | 7.05B | 0 | 5.71B | 0 | 2.01B | 0 | 4.24B |
Payments for dividends | -7.44B | -7.01B | -6.61B | -6.21B | -5.69B | -5.17B | -5.16B | -5.12B | -5.11B | -5.24B |
Repurchases of common stock | -1.34B | -384M | -840M | -1.28B | -4.78B | -9.09B | -4.01B | -3.43B | -4.18B | -7.70B |
Repayments of term debt | 4.18B | -2.25B | -2.31B | -1.95B | 1.24B | -4.28B | -1.12B | -2.38B | 3.49B | -6.61B |
Cash used in financing activities | -4.81B | -9.11B | 2.59B | -2.83B | -8.86B | -13.16B | -10.00B | -9.04B | -5.38B | -15.11B |
Net Change In Cash | -5.86B | 4.60B | 14M | -1.76B | 1.96B | 1.87B | -423M | -2.00B | 1.08B | -8.18B |
Cash at end of period | 6.90B | 12.77B | 8.16B | 8.16B | 9.93B | 7.96B | 6.09B | 6.51B | 8.52B | 7.44B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |